Literature DB >> 23278169

The evolution of a migraine attack - a review of recent evidence.

Andrew Charles1.   

Abstract

A migraine attack is an extraordinarily complex brain event that takes place over hours to days. This review focuses on recent human studies that shed light on the evolution of a migraine attack. It begins with a constellation of premonitory symptoms that are associated with activation of the hypothalamus and may involve the neurotransmitter dopamine. Even in the premonitory phase, patients experience sensitivity to sensory stimuli, indicating that central sensitization is a primary phenomenon. The migraine attack progresses to a phase that in some patients includes aura, which involves changes in cortical function, blood flow, and neurovascular coupling. The aura phase overlaps with the headache phase, which is associated with further changes in blood flow and function of the brainstem, thalamus, hypothalamus, and cortex. Serotonin receptors, nitric oxide, calcitonin gene-related peptide, pituitary adenylate cyclase-activating polypeptide, and prostanoids are demonstrated specific chemical mediators of migraine based on therapeutic and triggered migraine studies. A number of migraine symptoms persist beyond resolution of headache into a postdromal phase, accompanied by persistent blood flow changes in several brain regions. Although these phases of migraine have substantial temporal, neurochemical, and anatomical overlap, each represents an important window onto the pathophysiology of migraine as well as a target for therapeutic intervention. A comprehensive approach to migraine requires an understanding of the entire range of mechanisms and resultant symptoms that occur throughout the evolution of an attack.
© 2012 American Headache Society.

Entities:  

Mesh:

Year:  2012        PMID: 23278169     DOI: 10.1111/head.12026

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  44 in total

Review 1.  Migraine and triggers: post hoc ergo propter hoc?

Authors:  Jan Hoffmann; Ana Recober
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 2.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 3.  Orofacial pain and headache: a review and look at the commonalities.

Authors:  Steven D Bender
Journal:  Curr Pain Headache Rep       Date:  2014-03

Review 4.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

5.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

Review 6.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

Review 7.  The Face of Chronic Migraine Which Has Started to be Clarified.

Authors:  Zeynep Aydin Özemir; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

8.  Increased intrinsic brain connectivity between pons and somatosensory cortex during attacks of migraine with aura.

Authors:  Anders Hougaard; Faisal Mohammad Amin; Henrik B W Larsson; Egill Rostrup; Messoud Ashina
Journal:  Hum Brain Mapp       Date:  2017-02-27       Impact factor: 5.038

Review 9.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 10.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.